Biobanking—Budgets and the Role of Pathology Biobanks in Precision Medicine

Chris Andry, Elizabeth Duffy, Christopher A. Moskaluk, Shannon McCall, Michael H.A. Roehrl, Daniel Remick*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Biobanks have become an important component of the routine practice of pathology. At the 2016 meeting of the Association of Pathology Chairs, a series of presentations covered several important aspects of biobanking. An often overlooked aspect of biobanking is the fiscal considerations. A biobank budget must address the costs of consenting, procuring, processing, and preserving high-quality biospecimens. Multiple revenue streams will frequently be necessary to create a sustainable biobank; partnering with other key stakeholders has been shown to be successful at academic institutions which may serve as a model. Biobanking needs to be a deeply science-driven and innovating process so that specimens help transform patient-centered clinical and basic research (ie, fulfill the promise of precision medicine). Pathology’s role must be at the center of the biobanking process. This ensures that optimal research samples are collected while guaranteeing that clinical diagnostics are never impaired. Biobanks will continue to grow as important components in the mission of pathology, especially in the era of precision medicine.

Original languageEnglish
JournalAcademic Pathology
StatePublished - 2017
Externally publishedYes


  • The Cancer Genome Atlas
  • biorepository
  • informed consent
  • precision medicine
  • the Cancer Human Biobank


Dive into the research topics of 'Biobanking—Budgets and the Role of Pathology Biobanks in Precision Medicine'. Together they form a unique fingerprint.

Cite this